Behind every clinical trial that starts late, a patient is waiting for a treatment. Cori Clinical is the intelligence layer for accelerating clinical trials, creating a living blueprint of a trial from initial idea through to execution. Its unified workspace turns a clinical team's collective insight and organisational experience, enriched with trusted external intelligence, helping teams identify risks, assess options and connect study design with the practical requirements of running a trial. Cori surfaces and structures the evidence, while clinical teams retain responsibility for judgement and approval. Less time is lost to reconciling data, documents and version conflicts, so more time is available for the decisions that move a trial forward. No patient should have to wait when the science is ready but the process is too slow.
Cori Clinical: Venture Capital Funding History
Cori Clinical
Cori Clinical
- Life Sciences
- London, United Kingdom
- £3m
- cori-clinical.com
- Update Information
More venture news
- 7 Oct 2026

Cori ClinicalCori Clinical unlocks a £3m seed round led by Breega for an AI workspace improving clinical trial design
SeedLife Sciences - 23 Sept 2026

Basecamp ResearchBasecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Series CLife Sciences - 18 Sept 2026

Big Picture BioBig Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Pre-seedLife Sciences
